Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.

Authors	L S Goodman, M M Wintrobe, W Dameshek, M J Goodman, A Gilman, M T McLennan
Journal	JAMA (JAMA) Vol. 251 Issue 17 Pg. 2255-61 (May 04 1984) ISSN: 0098-7484 [Print] United States
PMID	6368885 (Publication Type: Biography, Historical Article, Journal Article)
Chemical References	Nitrogen Mustard Compounds Mechlorethamine 2,2',2''-trichlorotriethylamine
Topics	History, 20th Century Hodgkin Disease (drug therapy, history) Humans Leukemia (drug therapy, history) Lymphoma, Non-Hodgkin (drug therapy, history) Mechlorethamine (history, therapeutic use) Neoplasms (drug therapy, history) Nitrogen Mustard Compounds (history, therapeutic use) United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!